DK3737470T5 - 3-phenyl-4-hexynsyrederivater som gpr40-agonister - Google Patents
3-phenyl-4-hexynsyrederivater som gpr40-agonister Download PDFInfo
- Publication number
- DK3737470T5 DK3737470T5 DK19701029.1T DK19701029T DK3737470T5 DK 3737470 T5 DK3737470 T5 DK 3737470T5 DK 19701029 T DK19701029 T DK 19701029T DK 3737470 T5 DK3737470 T5 DK 3737470T5
- Authority
- DK
- Denmark
- Prior art keywords
- phenyl
- acid derivatives
- gpr40 agonists
- hexynic acid
- hexynic
- Prior art date
Links
- WZDFDFHBXGKMEU-UHFFFAOYSA-N CC#CC(CC(O)=O)C1=CC=CC=C1 Chemical class CC#CC(CC(O)=O)C1=CC=CC=C1 WZDFDFHBXGKMEU-UHFFFAOYSA-N 0.000 title 1
- 102100026148 Free fatty acid receptor 1 Human genes 0.000 title 1
- 101000912510 Homo sapiens Free fatty acid receptor 1 Proteins 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
- C07C57/42—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
- C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
- C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL424227A PL233938B1 (pl) | 2018-01-08 | 2018-01-08 | Pochodne kwasu 3-fenylo-4-heksynowego jako agoniści GPR40 |
| PL42562518 | 2018-05-18 | ||
| PCT/EP2019/050194 WO2019134984A1 (en) | 2018-01-08 | 2019-01-07 | 3-phenyl-4-hexynoic acid derivatives as gpr40 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3737470T3 DK3737470T3 (da) | 2023-03-13 |
| DK3737470T5 true DK3737470T5 (da) | 2024-05-27 |
Family
ID=67144423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19701029.1T DK3737470T5 (da) | 2018-01-08 | 2019-01-07 | 3-phenyl-4-hexynsyrederivater som gpr40-agonister |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11964938B2 (da) |
| EP (1) | EP3737470B9 (da) |
| JP (1) | JP7289305B2 (da) |
| KR (1) | KR20200108318A (da) |
| CN (1) | CN111757770B (da) |
| AU (1) | AU2019205093B2 (da) |
| BR (1) | BR112020013694A2 (da) |
| CA (1) | CA3087712A1 (da) |
| DK (1) | DK3737470T5 (da) |
| ES (1) | ES2939720T3 (da) |
| FI (1) | FI3737470T3 (da) |
| MX (1) | MX2020007283A (da) |
| PL (1) | PL3737470T3 (da) |
| PT (1) | PT3737470T (da) |
| WO (1) | WO2019134984A1 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021071837A1 (en) | 2019-10-07 | 2021-04-15 | Kallyope, Inc. | Gpr119 agonists |
| MX2022014505A (es) | 2020-05-19 | 2022-12-13 | Kallyope Inc | Activadores de la ampk. |
| JP2023531726A (ja) | 2020-06-26 | 2023-07-25 | キャリーオペ，インク． | Ａｍｐｋアクチベーター |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2385032A1 (en) | 2002-11-08 | 2011-11-09 | Takeda Pharmaceutical Company Limited | GPR40 Receptor function regulator |
| CA2527691C (en) | 2003-05-30 | 2013-01-22 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| TW200523247A (en) | 2003-12-25 | 2005-07-16 | Takeda Pharmaceutical | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| AU2005220728B2 (en) | 2004-02-27 | 2009-08-06 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| EP1726580A4 (en) | 2004-03-15 | 2008-02-13 | Takeda Pharmaceutical | AMINOPHNYLPROPANO ACID DERIVATIVE |
| US7989457B2 (en) | 2004-05-28 | 2011-08-02 | Eli Lilly And Company | Glucagon receptor antagonists, preparation and therapeutic uses |
| CA2621949A1 (en) | 2005-09-14 | 2007-03-22 | Amgen Inc. | Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
| RU2444521C2 (ru) | 2006-06-27 | 2012-03-10 | Такеда Фармасьютикал Компани Лимитед | Конденсированные циклические соединения |
| EP2064193A1 (en) | 2006-09-07 | 2009-06-03 | Amgen, Inc | Heterocyclic gpr40 modulators |
| US7750048B2 (en) | 2006-11-15 | 2010-07-06 | Janssen Pharmaceutica Nv | GPR40 agonists |
| CA2683751C (en) | 2007-04-16 | 2013-01-08 | Amgen Inc. | Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators |
| JP5657578B2 (ja) | 2009-06-09 | 2015-01-21 | 武田薬品工業株式会社 | 新規な縮合環化合物およびその用途 |
| AR078522A1 (es) | 2009-10-15 | 2011-11-16 | Lilly Co Eli | Compuesto de espiropiperidina, composicion farmaceutica que lo comprende, su uso para preparar un medicamento util para tratar diabetes y compuesto intermediario para su sintesis |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| CA2805808A1 (en) | 2010-07-23 | 2012-01-26 | Connexios Life Sciences Pvt. Ltd. | Agonists of gpr40 |
| JP6054368B2 (ja) | 2011-04-08 | 2016-12-27 | カルダン セラピューティクス リミテッドＣａｌｄａｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ | 代謝性疾患治療用ｏ−フルオロ置換化合物またはその塩 |
| TWI537262B (zh) | 2011-08-17 | 2016-06-11 | 美國禮來大藥廠 | 供治療糖尿病使用之新穎１，２，３，４－四氫喹啉衍生物 |
| EP2838891B1 (en) | 2012-02-24 | 2017-08-02 | Takeda Pharmaceutical Company Limited | Aromatic ring compound as ghrelin o-acyltransferase inhibitor |
| NZ631569A (en) | 2012-02-28 | 2016-10-28 | Piramal Entpr Ltd | Phenyl alkanoic acid derivatives as gpr agonists |
| MX2016008910A (es) | 2014-01-10 | 2016-10-04 | Lilly Co Eli | Compuestos de fenil-triazolo-piridina. |
| CN111423408A (zh) * | 2014-10-17 | 2020-07-17 | 现代药品株式会社 | 代谢性疾病的预防或治疗用复合制剂 |
-
2019
- 2019-01-07 US US16/960,700 patent/US11964938B2/en active Active
- 2019-01-07 EP EP19701029.1A patent/EP3737470B9/en active Active
- 2019-01-07 JP JP2020537648A patent/JP7289305B2/ja active Active
- 2019-01-07 ES ES19701029T patent/ES2939720T3/es active Active
- 2019-01-07 WO PCT/EP2019/050194 patent/WO2019134984A1/en unknown
- 2019-01-07 FI FIEP19701029.1T patent/FI3737470T3/fi active
- 2019-01-07 PL PL19701029.1T patent/PL3737470T3/pl unknown
- 2019-01-07 MX MX2020007283A patent/MX2020007283A/es unknown
- 2019-01-07 CA CA3087712A patent/CA3087712A1/en active Pending
- 2019-01-07 DK DK19701029.1T patent/DK3737470T5/da active
- 2019-01-07 AU AU2019205093A patent/AU2019205093B2/en active Active
- 2019-01-07 KR KR1020207022946A patent/KR20200108318A/ko not_active Application Discontinuation
- 2019-01-07 PT PT197010291T patent/PT3737470T/pt unknown
- 2019-01-07 CN CN201980007754.0A patent/CN111757770B/zh active Active
- 2019-01-07 BR BR112020013694-8A patent/BR112020013694A2/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020013694A2 (pt) | 2020-12-01 |
| AU2019205093B2 (en) | 2024-03-07 |
| KR20200108318A (ko) | 2020-09-17 |
| PT3737470T (pt) | 2023-03-02 |
| EP3737470B9 (en) | 2024-03-13 |
| JP7289305B2 (ja) | 2023-06-09 |
| CN111757770A (zh) | 2020-10-09 |
| PL3737470T3 (pl) | 2023-05-08 |
| AU2019205093A1 (en) | 2020-07-16 |
| EP3737470B1 (en) | 2022-12-14 |
| ES2939720T3 (es) | 2023-04-26 |
| JP2021509909A (ja) | 2021-04-08 |
| FI3737470T3 (fi) | 2023-03-19 |
| MX2020007283A (es) | 2020-09-10 |
| US11964938B2 (en) | 2024-04-23 |
| DK3737470T3 (da) | 2023-03-13 |
| CN111757770B (zh) | 2023-10-03 |
| CA3087712A1 (en) | 2019-07-11 |
| US20200399198A1 (en) | 2020-12-24 |
| EP3737470A1 (en) | 2020-11-18 |
| WO2019134984A1 (en) | 2019-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3873903T3 (da) | Substituerede 6-azabenzimidazolforbindelser som hpk1-hæmmere | |
| DK3494115T3 (da) | N-(phenylsulfonyl)benzamidderivater som bcl-2-hæmmere | |
| DK3313832T3 (da) | 3-tetrazolyl-benzen-1,2-disulfonamidderivater som metallo-beta- lactamase-hæmmere | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| DK3277677T3 (da) | 1-cyano-pyrrolidinforbindelser som usp30-hæmmere | |
| DK3381918T3 (da) | 7-(Thiazol-5-yl)-pyrrolopyrimidinforbindelse som TLR7-agonist | |
| DK3292116T3 (da) | 3-aryl-4-amido-bicykliske [4,5,0]hydroxamsyrer som hdac-inhibitorer | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| DK3339294T3 (da) | Quinolonderivat, farmaceutisk acceptabelt salt eller stereoisomer deraf som AXL hæmmer | |
| DK3986890T3 (da) | Benzisoxazol-sulfonamid-derivater | |
| DK3303305T3 (da) | 2-(phenyloxy eller phenylthio)pyrimidin-derivater som herbicider | |
| DK3302448T3 (da) | Erstattede heterocyclylafledninger som cdk-inhibitore | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3330259T3 (da) | 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| MA49908A (fr) | Composés inhibant la protéine mcl-1 | |
| DK3609898T3 (da) | Forbindelser, der er nyttige som ret-hæmmere | |
| DK3271349T3 (da) | Benzimidazolederivater som bromodomain-inhibitorer | |
| DK3580220T3 (da) | Aminotriazolpyridiner som kinasehæmmere | |
| DK3601225T3 (da) | Substituerede indolinderivater som inhibitorer af denguevirus-replikation | |
| DK3233843T3 (da) | Isoxazol-hydraxamsyreforbindelser som LPXC-hæmmere | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3562810T3 (da) | Benzhydroxamsyre-derivater som selektive hdac6-inhibitorer | |
| DK3013796T3 (da) | Biarylderivater som gpr120-agonister | |
| DK3497085T3 (da) | Sulfonamider som gpr40- og gpr120-agonister |